Developer docs
API playgroundTry for free, no card

Search company profiles

bonyf

Full company profile

uuid003vi33

Namestring
bonyf
Legal namestring
bonyf AG
Websiteurl
bonyf.com
Company typeenum
Public
Founded yearint
1979
Descriptiontext

bonyf is a public Belgian-domiciled (bonyf NV) oral and dental care company founded in 1979, listed on Euronext Paris under ticker MLBON since March 2022. The company develops, manufactures, and commercializes a portfolio of 15 products across oral care (PerioTabs®, PerioCream®), denture care (OlivaFix Gold®, NitrAdine® Disinfecting Tablets, Alginate-Organic Fixative), orthodontic care, and wound/skincare (AphtoFix®, HeelFix®, FingerFix®). All products are manufactured in Switzerland under ISO 13485 conditions at bonyf Production AG, with proprietary R&D conducted in Liechtenstein's 'Dental Valley' (bonyf AG) and a corporate headquarters in Knokke-Heist, Belgium.

The company's technical foundation is the proprietary NitrAdine® anti-biofilm platform, which delivers a 5-log (99.999%) reduction against bacteria and 99.99% reduction against fungi and viruses without antibiotics or chlorhexidine. NitrAdine® is deployed across multiple SKUs and has been certified as an EU-MDR Class IIb medical device; PerioCream® holds EU-MDR Class IIa certification (September 2025). OlivaFix Gold® is positioned as the world's first healthy denture adhesive, replacing petroleum derivatives and zinc with 30% organic olive oil and delivering up to 24-hour hold. Clinical evidence includes peer-reviewed studies at University of Torino (PerioTabs®, 90% bleeding reduction), multi-center OlivaFix Gold® trials across France, Italy, and Romania (84.11% improvement), and University of Zurich collaborations.

bonyf operates a multi-channel revenue model combining branded consumer product sales through pharmacies and dental professionals, contract manufacturing and private label for major retailers (70% of 2024 sales), and licensing royalties in the US (Honest Pharma, May 2025) and India (Group Pharmaceuticals, November 2024, with 13.5% equity stake and bonyf India Ltd JV). Distribution spans 37 countries with growth concentrated in the US, India, Southeast Asia, and Japan. The company is pursuing a Nasdaq dual listing expected by end of 2026 to support further international expansion.

Short descriptiontext

bonyf is a Swiss-manufactured public oral and dental care company selling 15 anti-biofilm, denture-care, and wound-care products across 37 countries via dental professionals, pharmacies, retail private label, and licensing partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVaduz, Liechtenstein
HQ citystring
Vaduz
HQ countrystring
Liechtenstein
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oral care products, denture adhesives, periodontal treatments, anti-biofilm technology, private label manufacturing
Industry2 codes
PRIMARYCRABAFAG
Denture Care (Adhesives, Cleansers, Reliners)
SECONDARYCRADANAC
Hand & Body Care (Lotions, Creams, Body Oils)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)
NAICS code2 codes
  • Dental Equipment and Supplies Manufacturing339114
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Dental Equipment & Supplies3843
  • Surgical & Medical Instruments & Apparatus3841
Product category
Oral and Dental Care Products
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Product Sales - Consumer Oral Care
TypeOne Time License
Description

Direct sales of branded oral care products including PerioTabs®, OlivaFix Gold®, and NitrAdine® tablets through pharmacies, retailers, and dental professionals. Revenue from both own-brand and private label/contract manufacturing. Private label sales grew from 37% in 2023 to 70% in 2024.

bonyf.com
2Licensing Royalties - India
TypeLicensing Royalties
Description

Licensing agreement with Group Pharmaceuticals for local production and distribution of NitrAdine® formulation and other bonyf products in India. Generates royalty revenue while enabling market expansion without capital investment.

einpresswire.com
3Licensing Royalties - US
TypeLicensing Royalties
Description

Partnership with Honest Pharma for US market access with products developed in Switzerland. Honest Pharma acts as exclusive importer, with potential warrant issuance if revenue milestones are met.

bonyf.com
4Contract Manufacturing / Private Label
TypeProfessional Services
Description

Manufacturing services for retail chains and international drugstores under long-duration contracts. Leverages Swiss manufacturing facility and MDR compliance to serve private label clients. Significant growth driver in 2024.

bonyf.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Infrastructure
Pricing details1 tier
1PerioTabs® 10-day treatment course
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Affordable price point mentioned in company communications. Available through pharmacies and retailers.

bonyf.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1OlivaFix Gold
Description

World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free formulation providing up to 24 hours hold

bonyf.com
+7 more records
Core offering1 text field

bonyf develops, manufactures and markets oral care, denture care, orthodontic care, and wound care products under proprietary NitrAdine® anti-biofilm technology. Its portfolio spans 15 products manufactured in Switzerland, including denture adhesives (OlivaFix Gold®), periodontal treatments (PerioTabs®, PerioCream®), disinfecting tablets, mouth ulcer creams, and skincare formulations, sold through dental professionals, pharmacies, retail chains, and private label partnerships across 37 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 99.999% bacteria reduction (5-log reduction) with NitrAdine® technology
+7 more records
Product overview1 text field

bonyf is a Swiss premium quality company specializing in the development, production, and marketing of oral, denture, orthodontic, and wound care products. The company operates a portfolio of 15 products organized into four category groups: oral care (PerioTabs, PerioCream, NitrAdine-based treatments), denture care (OlivaFix Gold, Alginate-Organic Denture Fixative Cream, NitrAdine Disinfecting Tablets), orthodontic care, and wound/skincare (AphtoFix, HeelFix, FingerFix). The core technology platform NitrAdine powers multiple products, providing anti-biofilm disinfection and treatment capabilities. Products are manufactured in Switzerland with in-house R&D conducted in Liechtenstein. Distribution spans 37 countries with recent expansion into the U.S. and India markets.

Product and service11 records
1PerioTabs®
CategoryOral care
Description

Revolutionary brushing solution in effervescent tablet form that dissolves in water to create a treatment solution targeting oral biofilm on gums, teeth, and dental implants. Reduces gingivitis, periodontitis, peri-mucositis, and peri-implantitis without chlorhexidine. Based on NitrAdine® anti-biofilm technology. For dental professionals and consumers.

2OlivaFix Gold®
CategoryDenture care
Description

World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free, with no petroleum derivatives or mineral oil. Provides up to 24 hours hold for upper dentures. Clinically proven superior holding time and antimycotic effect against Candida albicans. For denture wearers.

3PerioCream®
CategoryPeriodontal care
Description

Mucoadhesive periodontal paste applied by dental professionals as an adjunct to Scaling and Root Planing (SRP). Forms a protective barrier over the gum line, reduces bleeding, alleviates pain, and promotes faster healing. EU-MDR Class IIa certified medical device. For dental professionals.

4NitrAdine® Disinfecting Tablets
CategoryDenture care
Description

Deep-cleaning effervescent tablet for all types of dental appliances including dentures. Provides 5-log (99.999%) disinfection against bacteria and 99.99% against fungi and viruses. Class IIb medical device under EU-MDR. For denture wearers and dental professionals.

5AphtoFix®
CategoryWound care
Description

Fast pain-relief mouth ulcer cream with muco-adhesive property that forms a protective barrier against the oral environment, promoting rapid healing. Average healing time of 7 days with significant pain reduction from day 1. For consumers with mouth ulcers.

6HeelFix®
CategorySkincare / Wound care
Description

Advanced skincare formula for fast relief from heel cracks. Non-greasy, non-sticky Swiss-made formulation that provides pain relief from first application and substantial healing with continued use. For consumers with cracked skin conditions.

7FingerFix®
CategorySkincare / Wound care
Description

Skincare product for finger care applications, addressing finger cracks and skin regeneration. Part of the company's advanced skincare portfolio manufactured in Switzerland.

8BonyPlus®
CategoryOral care
Description

Oral care product in the company's portfolio. Manufactured in Switzerland under ISO certified quality standards.

9Advanced Dental Bleaching & Gum Reinforcement Kit
CategoryOrthodontic / Oral care
Description

Innovative system delivering superior dental bleaching results while actively reinforcing gum health. Designed for end users/consumers seeking aesthetic dental treatments combined with gum care benefits. Showcased at IDS Cologne 2025.

10Post-Scaling Care Kit
CategoryPeriodontal care
Description

Professional dental product exclusively designed for dentists to address post-scaling challenges. Significantly reduces pain and bleeding following scaling procedures to enhance patient comfort and satisfaction. Showcased at IDS Cologne 2025.

11Contract Manufacturing / Private Label Services
CategoryManufacturing services
Description

Contract manufacturing and private label services for retail chains and international drugstores. Leverages Swiss manufacturing facility and MDR/ISO 13485 compliance to serve private label clients with oral care products. Long-duration contracts represent a significant and growing revenue stream.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierSupportingTypeOthersAnnounced on2025-09-17
Description

Notified body that conducted EU-MDR certification process for PerioCream Class IIa medical device. Certification confirms compliance with EU health tech regulations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-03
Description

Strategic partnership with leading Indian oral health company. Group Pharmaceuticals acquired 13.5% stake in bonyf NV and will produce licensed bonyf products locally in India. Field force reaches over 100,000 dentists monthly. Both companies committed to co-developing new oral care solutions tailored for Indian market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-12-10
Description

Exclusive importer and distributor for US market. Strategic alliance to bring revolutionary oral care products to American consumers and dental professionals. Products meet FDA requirements while maintaining Swiss quality standards. Honest Pharma backed by Investment 360 with strong healthcare distribution network.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-11-28
Description

License agreement on NitrAdine® formulation for local manufacturing and distribution in India. Production planned to begin in early 2025 at Group Pharmaceuticals' cGMP-compliant facility near Mumbai. Enables large-scale manufacturing and distribution in Indian and Southeast Asian markets.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Distributors from five European countries expressing partnership intent for PerioCream rollout. Dental Depots serve as key distribution channel for professional dental products across Europe.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic research partner evaluating prophylactic and therapeutic efficacy of PerioTabs® through clinical studies. Published preliminary research in Applied Sciences journal.

7CIR-Dental School, University of Torino
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical research partner conducting gingivitis study in collaboration with periodontologists at Studio Sicor (Torino). Study published in European Journal of Dentistry demonstrating PerioTabs® efficacy.

bonyf.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spun out of GSK in 2022, Haleon owns leading denture adhesive brands Polident and Poligrip as well as Sensodyne toothpaste. It is the closest direct peer in denture adhesives and adjacent oral care, competing with bonyf's OlivaFix Gold and NitrAdine tablets across retail pharmacy channels.

TypeDirect peer
Description

Spanish oral care specialist (Vitis, Interprox, Desensin) focused on dental professional channels and pharmacy retail in Europe and Latin America. Comparable in product range (toothpaste, mouthwash, interdental), channel mix, and European market positioning.

TypeRegional player
Description

German specialty pharma group with branded dermatology and consumer health products including select oral care adjacencies. Comparable as a small/mid-cap European specialty pharma pursuing branded consumer healthcare via retail and pharmacy channels.

TypeEmerging player
Description

Italian-listed dental pharmaceutical company specializing in oral care and dental anesthesia products. Comparable to bonyf as a smaller public dental-specialty player pursuing international expansion and dental professional channel sales.

TypeBroad incumbent
Description

US-listed CPG company with oral care offerings (Orajel, Batiste-adjacent personal care). Competes against bonyf's AphtoFix mouth ulcer cream and broader oral care portfolio via pharmacy retail distribution.

6Dentsply Sirona
TypeBroad incumbent
Description

Largest global dental equipment and consumables manufacturer. Overlaps with bonyf's professional dental channel focus and serves periodontists and dental specialists with overlapping clinical audiences, though at vastly greater scale and with broader equipment offerings.

TypeDirect peer
Description

Swiss-headquartered oral care specialist behind the GUM brand, with deep focus on periodontal and interdental products. Highly comparable to bonyf in clinical positioning, dental professional channel, and category focus on gum disease prevention.

TypeBroad incumbent
Description

Global oral care leader via Colgate, elmex, meridol, and other brands. Competes with bonyf in consumer oral care and denture products across the same retail and dental professional channels.

TypeBroad incumbent
Description

Owns the Fixodent denture adhesive brand and Crest oral care line. P&G is a broad CPG incumbent with massive R&D and marketing budgets and global retail reach, competing against bonyf in denture fixation and oral hygiene.

TypeBroad incumbent
Description

French pharmaceutical and dermo-cosmetic group with an oral care portfolio (Elgydium, Arthrodont) sold primarily through dental professionals and pharmacies in Europe. Overlaps with bonyf's professional channel focus and European pharmacy distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

bonyf

Oral and Dental Care Productsbonyf.com

bonyf is a Swiss-manufactured public oral and dental care company selling 15 anti-biofilm, denture-care, and wound-care products across 37 countries via dental professionals, pharmacies, retail private label, and licensing partnerships.

What bonyf does

bonyf is a public Belgian-domiciled (bonyf NV) oral and dental care company founded in 1979, listed on Euronext Paris under ticker MLBON since March 2022. The company develops, manufactures, and commercializes a portfolio of 15 products across oral care (PerioTabs®, PerioCream®), denture care (OlivaFix Gold®, NitrAdine® Disinfecting Tablets, Alginate-Organic Fixative), orthodontic care, and wound/skincare (AphtoFix®, HeelFix®, FingerFix®). All products are manufactured in Switzerland under ISO 13485 conditions at bonyf Production AG, with proprietary R&D conducted in Liechtenstein's 'Dental Valley' (bonyf AG) and a corporate headquarters in Knokke-Heist, Belgium.

The company's technical foundation is the proprietary NitrAdine® anti-biofilm platform, which delivers a 5-log (99.999%) reduction against bacteria and 99.99% reduction against fungi and viruses without antibiotics or chlorhexidine. NitrAdine® is deployed across multiple SKUs and has been certified as an EU-MDR Class IIb medical device; PerioCream® holds EU-MDR Class IIa certification (September 2025). OlivaFix Gold® is positioned as the world's first healthy denture adhesive, replacing petroleum derivatives and zinc with 30% organic olive oil and delivering up to 24-hour hold. Clinical evidence includes peer-reviewed studies at University of Torino (PerioTabs®, 90% bleeding reduction), multi-center OlivaFix Gold® trials across France, Italy, and Romania (84.11% improvement), and University of Zurich collaborations.

bonyf operates a multi-channel revenue model combining branded consumer product sales through pharmacies and dental professionals, contract manufacturing and private label for major retailers (70% of 2024 sales), and licensing royalties in the US (Honest Pharma, May 2025) and India (Group Pharmaceuticals, November 2024, with 13.5% equity stake and bonyf India Ltd JV). Distribution spans 37 countries with growth concentrated in the US, India, Southeast Asia, and Japan. The company is pursuing a Nasdaq dual listing expected by end of 2026 to support further international expansion.

bonyf firmographics

Firmographics
Name
bonyf
Legal name
bonyf AG
Website
https://bonyf.com
Company type
Public
Founded year
1979
Operating status
Operating
Headcount range
11–50 employees
Short description
bonyf is a Swiss-manufactured public oral and dental care company selling 15 anti-biofilm, denture-care, and wound-care products across 37 countries via dental professionals, pharmacies, retail private label, and licensing partnerships.
Ownership category
akta.pro rank

bonyf industry classification

Industry
Product category
Oral and Dental Care Products
NAICS
Dental Equipment and Supplies Manufacturing (339114), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRABAFAG
Denture Care (Adhesives, Cleansers, Reliners)
SECONDARYCRADANAC
Hand & Body Care (Lotions, Creams, Body Oils)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)

Keywords

  • Oral care products
  • Denture adhesives
  • Periodontal treatments
  • Anti-biofilm technology
  • Private label manufacturing

Where bonyf is headquartered

Location

Headquarters

HQ city
Vaduz
HQ country
Liechtenstein
HQ region
Europe

Offices4 records

Markets served

bonyf business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Infrastructure

Revenue model

  1. Product Sales - Consumer Oral Care: Direct sales of branded oral care products including PerioTabs®, OlivaFix Gold®, and NitrAdine® tablets through pharmacies, retailers, and dental professionals. Revenue from both own-brand and private label/contract manufacturing. Private label sales grew from 37% in 2023 to 70% in 2024.
  2. Licensing Royalties - India: Licensing agreement with Group Pharmaceuticals for local production and distribution of NitrAdine® formulation and other bonyf products in India. Generates royalty revenue while enabling market expansion without capital investment.
  3. Licensing Royalties - US: Partnership with Honest Pharma for US market access with products developed in Switzerland. Honest Pharma acts as exclusive importer, with potential warrant issuance if revenue milestones are met.
  4. Contract Manufacturing / Private Label: Manufacturing services for retail chains and international drugstores under long-duration contracts. Leverages Swiss manufacturing facility and MDR compliance to serve private label clients. Significant growth driver in 2024.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPerioTabs® 10-day treatment course

Go-to-market motion3 records

Distribution channels8 records

Marketing channels9 records

bonyf product offering

Product offering

Core offering

bonyf develops, manufactures and markets oral care, denture care, orthodontic care, and wound care products under proprietary NitrAdine® anti-biofilm technology. Its portfolio spans 15 products manufactured in Switzerland, including denture adhesives (OlivaFix Gold®), periodontal treatments (PerioTabs®, PerioCream®), disinfecting tablets, mouth ulcer creams, and skincare formulations, sold through dental professionals, pharmacies, retail chains, and private label partnerships across 37 countries.

Product overview

bonyf is a Swiss premium quality company specializing in the development, production, and marketing of oral, denture, orthodontic, and wound care products. The company operates a portfolio of 15 products organized into four category groups: oral care (PerioTabs, PerioCream, NitrAdine-based treatments), denture care (OlivaFix Gold, Alginate-Organic Denture Fixative Cream, NitrAdine Disinfecting Tablets), orthodontic care, and wound/skincare (AphtoFix, HeelFix, FingerFix). The core technology platform NitrAdine powers multiple products, providing anti-biofilm disinfection and treatment capabilities. Products are manufactured in Switzerland with in-house R&D conducted in Liechtenstein. Distribution spans 37 countries with recent expansion into the U.S. and India markets.

Differentiator

Problem solved

Functional benefit

Brands

  • OlivaFix Gold: World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free formulation providing up to 24 hours hold
  • PerioTabs
  • PerioCream
  • NitrAdine
  • AphtoFix
  • HeelFix
  • BonyPlus
  • FingerFix

Products and services

  • PerioTabs® Revolutionary brushing solution in effervescent tablet form that dissolves in water to create a treatment solution targeting oral biofilm on gums, teeth, and dental implants. Reduces gingivitis, periodontitis, peri-mucositis, and peri-implantitis without chlorhexidine. Based on NitrAdine® anti-biofilm technology. For dental professionals and consumers.
  • OlivaFix Gold® World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free, with no petroleum derivatives or mineral oil. Provides up to 24 hours hold for upper dentures. Clinically proven superior holding time and antimycotic effect against Candida albicans. For denture wearers.
  • PerioCream® Mucoadhesive periodontal paste applied by dental professionals as an adjunct to Scaling and Root Planing (SRP). Forms a protective barrier over the gum line, reduces bleeding, alleviates pain, and promotes faster healing. EU-MDR Class IIa certified medical device. For dental professionals.
  • NitrAdine® Disinfecting Tablets Deep-cleaning effervescent tablet for all types of dental appliances including dentures. Provides 5-log (99.999%) disinfection against bacteria and 99.99% against fungi and viruses. Class IIb medical device under EU-MDR. For denture wearers and dental professionals.
  • AphtoFix® Fast pain-relief mouth ulcer cream with muco-adhesive property that forms a protective barrier against the oral environment, promoting rapid healing. Average healing time of 7 days with significant pain reduction from day 1. For consumers with mouth ulcers.
  • HeelFix® Advanced skincare formula for fast relief from heel cracks. Non-greasy, non-sticky Swiss-made formulation that provides pain relief from first application and substantial healing with continued use. For consumers with cracked skin conditions.
  • FingerFix® Skincare product for finger care applications, addressing finger cracks and skin regeneration. Part of the company's advanced skincare portfolio manufactured in Switzerland.
  • BonyPlus® Oral care product in the company's portfolio. Manufactured in Switzerland under ISO certified quality standards.
  • Advanced Dental Bleaching & Gum Reinforcement Kit Innovative system delivering superior dental bleaching results while actively reinforcing gum health. Designed for end users/consumers seeking aesthetic dental treatments combined with gum care benefits. Showcased at IDS Cologne 2025.
  • Post-Scaling Care Kit Professional dental product exclusively designed for dentists to address post-scaling challenges. Significantly reduces pain and bleeding following scaling procedures to enhance patient comfort and satisfaction. Showcased at IDS Cologne 2025.
  • Contract Manufacturing / Private Label Services Contract manufacturing and private label services for retail chains and international drugstores. Leverages Swiss manufacturing facility and MDR/ISO 13485 compliance to serve private label clients with oral care products. Long-duration contracts represent a significant and growing revenue stream.

Quantifiable outcome

  • 99.999% bacteria reduction (5-log reduction) with NitrAdine® technology
  • +7 more outcomes

Companies that use bonyf

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

bonyf technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

bonyf partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered supporting, core and major.

  • DEKRA Certification GmbHsupportingOthers · 17 September 2025Notified body that conducted EU-MDR certification process for PerioCream Class IIa medical device. Certification confirms compliance with EU health tech regulations.
  • Group PharmaceuticalscoreStrategic or Co-development Partner · 3 June 2025Strategic partnership with leading Indian oral health company. Group Pharmaceuticals acquired 13.5% stake in bonyf NV and will produce licensed bonyf products locally in India. Field force reaches over 100,000 dentists monthly. Both companies committed to co-developing new oral care solutions tailored for Indian market.
  • Honest PharmacoreChannel Partner/ Reseller/ Distributor · 10 December 2024Exclusive importer and distributor for US market. Strategic alliance to bring revolutionary oral care products to American consumers and dental professionals. Products meet FDA requirements while maintaining Swiss quality standards. Honest Pharma backed by Investment 360 with strong healthcare distribution network.
  • Group Pharmaceuticals LtdcoreOEM/ Whitelabel/ Licensing Partner · 28 November 2024License agreement on NitrAdine® formulation for local manufacturing and distribution in India. Production planned to begin in early 2025 at Group Pharmaceuticals' cGMP-compliant facility near Mumbai. Enables large-scale manufacturing and distribution in Indian and Southeast Asian markets.
  • Dental Depots (European Distributors)majorChannel Partner/ Reseller/ DistributorDistributors from five European countries expressing partnership intent for PerioCream rollout. Dental Depots serve as key distribution channel for professional dental products across Europe.
  • University of ZurichsupportingStrategic or Co-development PartnerAcademic research partner evaluating prophylactic and therapeutic efficacy of PerioTabs® through clinical studies. Published preliminary research in Applied Sciences journal.
  • CIR-Dental School, University of TorinosupportingStrategic or Co-development PartnerClinical research partner conducting gingivitis study in collaboration with periodontologists at Studio Sicor (Torino). Study published in European Journal of Dentistry demonstrating PerioTabs® efficacy.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

bonyf competitors and assessment

Company assessment

Direct peers

  • Haleon: Spun out of GSK in 2022, Haleon owns leading denture adhesive brands Polident and Poligrip as well as Sensodyne toothpaste. It is the closest direct peer in denture adhesives and adjacent oral care, competing with bonyf's OlivaFix Gold and NitrAdine tablets across retail pharmacy channels.
  • Dentaid: Spanish oral care specialist (Vitis, Interprox, Desensin) focused on dental professional channels and pharmacy retail in Europe and Latin America. Comparable in product range (toothpaste, mouthwash, interdental), channel mix, and European market positioning.
  • Sunstar: Swiss-headquartered oral care specialist behind the GUM brand, with deep focus on periodontal and interdental products. Highly comparable to bonyf in clinical positioning, dental professional channel, and category focus on gum disease prevention.

Regional players

  • Dermapharm: German specialty pharma group with branded dermatology and consumer health products including select oral care adjacencies. Comparable as a small/mid-cap European specialty pharma pursuing branded consumer healthcare via retail and pharmacy channels.

Emerging players

  • Pierrel: Italian-listed dental pharmaceutical company specializing in oral care and dental anesthesia products. Comparable to bonyf as a smaller public dental-specialty player pursuing international expansion and dental professional channel sales.

Broad incumbents

  • Church & Dwight: US-listed CPG company with oral care offerings (Orajel, Batiste-adjacent personal care). Competes against bonyf's AphtoFix mouth ulcer cream and broader oral care portfolio via pharmacy retail distribution.
  • Dentsply Sirona: Largest global dental equipment and consumables manufacturer. Overlaps with bonyf's professional dental channel focus and serves periodontists and dental specialists with overlapping clinical audiences, though at vastly greater scale and with broader equipment offerings.
  • Colgate-Palmolive: Global oral care leader via Colgate, elmex, meridol, and other brands. Competes with bonyf in consumer oral care and denture products across the same retail and dental professional channels.
  • Procter & Gamble: Owns the Fixodent denture adhesive brand and Crest oral care line. P&G is a broad CPG incumbent with massive R&D and marketing budgets and global retail reach, competing against bonyf in denture fixation and oral hygiene.
  • Pierre Fabre: French pharmaceutical and dermo-cosmetic group with an oral care portfolio (Elgydium, Arthrodont) sold primarily through dental professionals and pharmacies in Europe. Overlaps with bonyf's professional channel focus and European pharmacy distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

bonyf social profiles

Digital presence

bonyf compliance and trust

Trust signal

Compliance7 records

bonyf financial estimates

Financial estimate

Revenue estimate

Valuation estimate

bonyf leadership team

Management profile

Number of profiles

Profiles3 records

bonyf subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

bonyf funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

bonyf M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bonyf

What does bonyf do?

bonyf develops, manufactures and markets oral care, denture care, orthodontic care, and wound care products under proprietary NitrAdine® anti-biofilm technology. Its portfolio spans 15 products manufactured in Switzerland, including denture adhesives (OlivaFix Gold®), periodontal treatments (PerioTabs®, PerioCream®), disinfecting tablets, mouth ulcer creams, and skincare formulations, sold through dental professionals, pharmacies, retail chains, and private label partnerships across 37 countries.

Is bonyf a public or private company?

bonyf is a public company. It is classified as public and is currently operating.

When was bonyf founded?

bonyf was founded in 1979. It employs 11 to 50 people.

Where is bonyf based?

bonyf is headquartered in Vaduz, Liechtenstein, in the Europe region.

How does bonyf make money?

Four revenue lines are on record. Product Sales - Consumer Oral Care is the primary driver. The others are licensing Royalties - India, licensing Royalties - US and contract Manufacturing / Private Label.

Who are bonyf's main competitors?

Direct peers on record are Haleon, Dentaid and Sunstar. Dermapharm is listed as a regional player. Pierrel is listed as an emerging player. Broad incumbents are Church & Dwight, Dentsply Sirona, Colgate-Palmolive, Procter & Gamble and Pierre Fabre.

Does bonyf have an API?

No public API is recorded for bonyf.

What industry is bonyf in?

bonyf's product category is Oral and Dental Care Products. Its primary akta.pro industry code is CRABAFAG, Denture Care (Adhesives, Cleansers, Reliners), with a secondary code of CRADANAC, Hand & Body Care (Lotions, Creams, Body Oils). Its NAICS code is 339114 and its SIC code is 3843.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN Presswirebonyf enters a new era of 'Renaissance' driven by its own brands and the international launch of PerioCreambonyf NV announced a strategic return to its own brands, with PerioCream launches planned for September 2026 in Italy, Poland, Spain, Croatia, and Slovenia. The company aims to enter the U.S. market before end of 2026, subject to FDA clearance. The transformation seeks to simplify its commercial model and strengthen proprietary brands.openPR.comCompetitive Landscape: Leading Companies and New Entrants in the Dental Adhesives and Sealants MarketThe dental adhesives and sealants market is projected to reach $10.44 billion by 2030, growing at a compound annual growth rate of 10.0%, driven by demand for bioactive materials, aesthetic dentistry, and minimally invasive treatment techniques. In May 2023, Tokuyama Dental Corporation acquired full ownership of Tokuyama Dental Deutschland GmbH from joint venture partner Euronda Deutschland GmbH, enabling independent management of its European sales activities. Additionally, Belgium-based Bonyf NV launched Olivafix Gold, a zinc-free denture adhesive made with 30% organic olive oil, in July 2024.EIN PresswireCompany Update on Market Trading Dynamics and Business Fundamentalsbonyf NV issued a clarification statement addressing recent stock price volatility and low trading liquidity, asserting that these market dynamics do not reflect the company's underlying operational performance or financial health. The company highlighted that 2025 has been transformational, with entries into the American market and the signing of an exclusive licensing agreement with Group Pharmaceuticals for the Indian market. Group Pharmaceuticals has also become a significant shareholder, holding 13.5% of bonyf's share capital, representing an important step in the company's global expansion strategy.EIN PresswirePerioCream becomes the most in-demand bonyf innovationbonyf NV announced a faster-than-forecasted commercial roll-out of its PerioCream Periodontal Paste product, having secured supplier agreements across three key strategic regions: West & East Europe, the United States, and Southeast Asia. The company has contracted distributors in the USA with distribution expected in Q2 2026 following FDA certification process initiation, while also securing agreements in 2 Southeast Asian countries and 4 European countries with first deliveries scheduled for Q1 2026. Initial orders from these agreements have already reached approximately 250,000 EUR just one month after EU MDR certification.EIN Presswirebonyf AG receives the EU-MDR Certification Class IIa for PerioCreambonyf AG has received EU-MDR Certification Class IIa for its PerioCream periodontal paste product, issued by DEKRA Certification GmbH on September 17, 2025, enabling worldwide distribution to dental professionals. The certification under Medical Device Regulation (EU) 2017/745 represents regulatory approval for the product to be marketed across European markets. The company has also initiated FDA certification for the US market, with approval expected in early 2026.PharmiWeb.combonyf NV Cancels Planned Capital Increase Following Positive Strategic Developmentsbonyf NV cancelled a planned capital increase on 5 September 2025, citing positive strategic developments. The company received auditor confirmation for its PerioCream product launch and is advancing FDA registration with its U.S. partner, expecting a faster global roll-out.Business Insiderbonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracksbonyf NV announced a new skincare formula for heel and finger cracks, developed by its R&D team. A clinical study showed the first application provides fast pain relief and a few applications lead to substantial healing. The product is currently available in limited markets with plans for broader distribution.GlobeNewswireOlivaFix - First Worldwide Healthy Denture Adhesive Cream - Coming to Americabonyf AG, a Swiss health company, announced it will export its OlivaFix denture adhesive cream line to American consumers. The products contain zero petrochemicals, zinc, and parabens, with 30% organic olive oil, and last 24 hours for upper dentures.